September 18, 2024 AATec Medical Welcomes Professor James Chalmers to Scientific Advisory Board Read More
July 24, 2024 AATec Medical reports significant progress in company’s first year towards unlocking the therapeutic potential of AAT Read More
February 29, 2024 AATec Medical appoints Professor Dr. Claus Franz Vogelmeier to the Scientific Advisory Board Read More
February 23, 2024 AATec Medical starts collaboration with the German Federal Agency for Disruptive Innovation SPRIND for alpha-1 antitrypsin Read More
October 31, 2023 AATec Medical and Beurer enter development collaboration for inhaled Alpha-1 Antitrypsin Read More
July 17, 2023 AATec Medical Announces its Launch with EUR 2.7 million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin Read More
